CASTELLI, ROBERTO
CASTELLI, ROBERTO
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti
Acquired C1-inhibitor deficiency and lymphoproliferative disorders : a tight relationship
2013 R. Castelli, A. Zanichelli, M. Cicardi, M. Cugno
Acquired deficiency of the inhibitor of the first complement component : presentation, diagnosis, course, and conventional management
2006 L.C. Zingale, R. Castelli, A. Zanichelli, M. Cicardi
Acute idiopathic polyneuropathy after subcutaneous alemtuzumab (AL) therapy in chronic lymphocytic leukemia (CLL) patients
2009 G. Reda, R. Castelli, K. Aprile von Hohenstaufen Puoti, N. Orofino, G. Conti, A. Cortelezzi, N. Bresolin
Aggressive natural killer cell leukaemia with a complex karyotype : a case report
2006 R. Castelli, M. Molteni, U. Gianelli, L. Cro, M. Grimoldi, A. Cortelezzi
Angioedema due to acquired C1-inhibitor deficiency : a bridging condition between autoimmunity and lymphoproliferation
2008 M. Cugno, R. Castelli, M. Cicardi
Anti-t-PA antibodies in acute myocardial infarction after thrombolysis with rt-PA
2010 M. Cugno, R. Castelli, G. Bisiani, S. Griffini, P. L. Meroni
Cardiopulmonary by-pass in a patient with acquired C1 inhibitor deficiency
1997 R. Castelli, M. Cicardi, M. Gardinali, L. C. Zingale, C. Savi, M. Munari, A. Agostoni
Choosing treatment options for patients with relapsed/refractory multiple myeloma
2014 R. Castelli, N. Orofino, A. Losurdo, R. Gualtierotti, M. Cugno
Current and Emerging Treatment Options for Patients with Relapsed Myeloma
2013 R. Castelli, R. Gualtierotti, N. Orofino, A. Losurdo, S. Gandolfi, M. Cugno
Discrepancies between bone marrow histopathology and clinical phenotype in BCR-ABL1-negative myeloproliferative neoplasms associated with splanchnic vein thrombosis
2015 U. Gianelli, A. Iurlo, D. Cattaneo, A. Bossi, I. Cortinovis, C. Augello, A. Moro, F. Savi, R. Castelli, C. Brambilla, P. Bianchi, M. Primignani, A. Cortelezzi, S. Bosari
Effect of hydroxyurea on extramedullary haematopoiesis in thalassaemia intermedia : case reports and literature review
2008 A. Meo, E. Cassinerio, R. Castelli, D. Bignamini, L. Perego, M.D. Cappellini
Effect of hydroxyurea on extramedullary haematopoiesis in thalassemia intermedia : case reports and literature review
2007 R. Castelli, E. Cassinerio, A. Meo, G. Ogliari, R. Fasulo, M.D. Cappellini
ELEVATA INCIDENZA DI LINFOMI INDOLENTI NON FOLLICOLARI NEI PAZIENTI CON CARENZA ACQUISITA DI INIBITORI DELLA C1 ESTERASI
2016 R. Castelli
First-line treatment with bendamustine and rituximab, in patients with intermediate-/high-risk splenic marginal zone lymphomas
2018 R. Castelli, L.C. Bergamaschini, G.L. Deliliers
Gaucher disease - Pathophysiology and management of adult patients
2006 M.D. Cappellini, R. Castelli, E. Cassinerio
Guillain Barrè syndrome in a chronic lymphocytic leukaemia (CLL) patient after subcutaneous alemtuzumab (A) therapy
2009 R. Castelli, G. Moreo, B. Panfili, F. Cogiamanian, G. Reda, A. Cortelezzi, N. Bresolin, G. Conti
Heparin induced thrombocytopenia: pathogenetic, clinical, diagnostic and therapeutic aspects
2007 R. Castelli, E. Cassinerio, M.D. Cappellini, F. Porro, G. Graziadei, F. Fabris
High prevalence of heparin induced thrombocytopenia with thrombosis among patients with essential thrombocytemia carrying V617F mutation
2018 R. Castelli, P. Gallipoli, R. Schiavon, T. Teatini, G.L. Deliliers, L.C. Bergamaschini
High prevalence of splenic marginal zone lymphoma among patients with acquired C1 inhibtor deficiency
2016 R. Castelli, M.A. Wu, M. Arquati, A. Zanichelli, C. Suffritti, D. Rossi, M. Cicardi
High rate of hepatitis B viral breakthrough in elderly non-Hodgkin lymphomas patients treated with Rituximab based chemotherapy
2016 R. Castelli, L. Ferraris, G. Pantaleo, G. Lambertenghi Deliliers, M. Cicardi